FMP

FMP

Enter

TARA - Protara Therapeutics...

Financial Statements of Protara Therapeutics, Inc.(TARA), Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying a

photo-url-https://financialmodelingprep.com/image-stock/TARA.png

Protara Therapeutics, Inc.

TARA

NASDAQ

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

2.23 USD

-0.03 (-1.35%)

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep